• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药效团和二维分子指纹的酪蛋白水解蛋白酶抑制剂的从头设计。

De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints.

作者信息

Wu Guanzhong, Zhang Zhen, Chen Hong, Lin Kejiang

机构信息

School of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

School of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.

出版信息

Bioorg Med Chem Lett. 2015 Jun 1;25(11):2345-52. doi: 10.1016/j.bmcl.2015.04.035. Epub 2015 Apr 17.

DOI:10.1016/j.bmcl.2015.04.035
PMID:25937012
Abstract

Caseinolytic protein proteases (ClpP) are large oligomeric protein complexes that contribute to cell homeostasis as well as virulence regulation in bacteria. Inhibitors of ClpP can significantly attenuate the capability to produce virulence factors of the bacteria. In this work, we developed a workflow to expand the chemical space of potential ClpP inhibitors based on a set of β-lactones. In our workflow, an artificial pharmacophore model was generated based on HipHop and HYPOGEN method. A de novo compound library based on molecular fingerprints was constructed and virtually screened by the pharmacophore model. The results were further investigated by molecular docking study. The workflow successfully achieved potential ClpP inhibitors. It could be applied to design more novel potential ClpP inhibitors and provide theoretical basis for the further optimization of the hit compounds.

摘要

酪蛋白水解蛋白酶(ClpP)是大型寡聚蛋白复合物,有助于细菌的细胞稳态以及毒力调节。ClpP抑制剂可显著减弱细菌产生毒力因子的能力。在这项工作中,我们基于一组β-内酯开发了一种工作流程,以扩展潜在ClpP抑制剂的化学空间。在我们的工作流程中,基于HipHop和HYPOGEN方法生成了一个人工药效团模型。构建了基于分子指纹的全新化合物库,并通过药效团模型进行虚拟筛选。通过分子对接研究进一步研究结果。该工作流程成功获得了潜在的ClpP抑制剂。它可用于设计更多新型潜在ClpP抑制剂,并为命中化合物的进一步优化提供理论依据。

相似文献

1
De novo design of caseinolytic protein proteases inhibitors based on pharmacophore and 2D molecular fingerprints.基于药效团和二维分子指纹的酪蛋白水解蛋白酶抑制剂的从头设计。
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2345-52. doi: 10.1016/j.bmcl.2015.04.035. Epub 2015 Apr 17.
2
De novo design of novel DNA-gyrase inhibitors based on 2D molecular fingerprints.基于二维分子指纹的新型 DNA 拓扑异构酶抑制剂的从头设计。
Bioorg Med Chem Lett. 2013 Jul 15;23(14):4166-71. doi: 10.1016/j.bmcl.2013.05.033. Epub 2013 May 18.
3
Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.运用一些三维定量构效关系技术探索丙型肝炎病毒NS3蛋白酶的P2和P3配体结合特征。
J Mol Graph Model. 2008 Apr;26(7):1131-44. doi: 10.1016/j.jmgm.2007.10.005. Epub 2007 Oct 9.
4
Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization.苯酯是酪蛋白水解蛋白酶 P 的有效抑制剂,并揭示了其解寡聚作用的手性开关。
J Am Chem Soc. 2015 Jul 8;137(26):8475-83. doi: 10.1021/jacs.5b03084. Epub 2015 Jun 29.
5
Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent ClpP Inhibitors.鉴定和表征获批药物和类药性化合物作为 ClpP 的共价抑制剂。
Int J Mol Sci. 2019 May 31;20(11):2686. doi: 10.3390/ijms20112686.
6
Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP.开发和表征新型β-内酰胺类抗毒力药物,针对 ClpP。
Bioorg Med Chem. 2012 Jan 15;20(2):583-91. doi: 10.1016/j.bmc.2011.07.047. Epub 2011 Jul 29.
7
Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.基于反应的新型设计、合成与潜在的 II 型激酶抑制剂的测试。
Future Med Chem. 2011 Mar;3(4):415-24. doi: 10.4155/fmc.11.8.
8
Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus.β-内酯作为ClpP的特异性抑制剂可减弱金黄色葡萄球菌细胞外毒力因子的产生。
J Am Chem Soc. 2008 Nov 5;130(44):14400-1. doi: 10.1021/ja8051365. Epub 2008 Oct 11.
9
Bacterial proteases, untapped antimicrobial drug targets.细菌蛋白酶,未开发的抗菌药物靶点。
J Antibiot (Tokyo). 2017 Apr;70(4):366-377. doi: 10.1038/ja.2016.138. Epub 2016 Nov 30.
10
Design and synthesis of tailored human caseinolytic protease P inhibitors.定制人组织蛋白酶 P 抑制剂的设计与合成。
Chem Commun (Camb). 2018 Aug 28;54(70):9833-9836. doi: 10.1039/c8cc05265d.

引用本文的文献

1
Rh-Catalyzed Conjugate Addition of Aryl and Alkenyl Boronic Acids to α-Methylene-β-lactones: Stereoselective Synthesis of trans-3,4-Disubstituted β-Lactones.铑催化的芳基和烯基硼酸与α-亚甲基-β-内酰胺的共轭加成:反式-3,4-二取代β-内酰胺的立体选择性合成。
Org Lett. 2017 Sep 1;19(17):4460-4463. doi: 10.1021/acs.orglett.7b01994. Epub 2017 Aug 15.